AptarGroup Inc (ATR)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $9.07B
Last updated: Nov 17, 2026 at 11:04 AM ET
AptarGroup Inc (ATR) Financials: Revenue, Profit and Cash Flow
AptarGroup reported revenue of $3.78B for the fiscal year ended Dec 31, 2025, up 5.4% from the year before. That year, net income was $392.50M with a net margin of 10.4%, operating cash flow was $570.00M and free cash flow was $299.58M. The quarter ended Sep 30, 2026 had revenue of $1.02B and net income of $32.82M.
Revenue and Margins
The operating margin was 13.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $2.33B, a compound annual rate of 5.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $3.78B | +5.4% | 37.2% | 13.3% | 10.4% |
| Dec 2024 | $3.58B | +2.7% | 37.8% | 13.9% | 10.4% |
| Dec 2023 | $3.49B | +5.0% | 36.2% | 11.6% | 8.1% |
| Dec 2022 | $3.32B | +2.9% | 35.0% | 11.4% | 7.2% |
| Dec 2021 | $3.23B | +10.2% | 35.8% | 10.8% | 7.5% |
| Dec 2020 | $2.93B | +2.4% | 37.1% | 11.6% | 7.3% |
| Dec 2019 | $2.86B | +3.4% | 36.4% | 13.0% | 8.5% |
| Dec 2018 | $2.76B | +12.0% | 34.4% | 10.4% | 7.0% |
| Dec 2017 | $2.47B | +5.9% | 35.1% | 13.1% | 8.9% |
| Dec 2016 | $2.33B | N/A | 35.8% | 13.5% | 8.8% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 4.9% from the year before. In the quarter ended Sep 2026, net income fell 74.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.78B | $3.58B | $3.49B | $3.32B | $3.23B | $2.93B | $2.86B | $2.76B | $2.47B | $2.33B |
| Cost of revenue | $2.37B | $2.23B | $2.22B | $2.16B | $2.07B | $1.84B | $1.82B | $1.81B | $1.60B | $1.50B |
| Gross profit | $1.40B | $1.36B | $1.26B | $1.16B | $1.16B | $1.09B | $1.04B | $951.80M | $866.21M | $834.76M |
| Research and development | $606.50M | $582.23M | $565.78M | $544.26M | $551.24M | $500.23M | $454.62M | $429.95M | $387.42M | $366.27M |
| Operating income | $501.04M | $496.50M | $404.02M | $379.27M | $347.35M | $339.50M | $371.69M | $286.27M | $323.49M | $313.69M |
| Net income | $392.50M | $374.18M | $284.18M | $239.56M | $243.64M | $214.09M | $242.23M | $194.77M | $220.03M | $205.60M |
| EBITDA | $812.89M | $763.55M | $655.82M | $608.18M | $579.11M | $552.12M | $567.80M | $463.57M | $483.27M | $468.08M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.02B | $1.03B | $982.87M | $962.74M | $961.13M | $966.01M | $887.30M | $848.09M | $909.29M | $910.06M | $915.45M | $838.48M |
| Gross profit | $372.92M | $365.52M | $351.91M | $338.22M | $363.08M | $367.01M | $336.41M | $329.41M | $350.78M | $342.62M | $332.69M | $312.25M |
| Operating income | $135.01M | $126.72M | $107.50M | $106.27M | $136.92M | $144.39M | $113.45M | $120.11M | $138.30M | $126.01M | $112.08M | $84.20M |
| Net income | $32.82M | $88.01M | $72.77M | $74.27M | $127.83M | $111.73M | $78.66M | $100.86M | $99.92M | $90.46M | $82.93M | $62.24M |
Balance Sheet
As of Dec 2025, total debt of $1.48B exceeded cash and equivalents by $1.08B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.25B | $4.43B | $4.45B | $4.20B | $4.14B | $3.99B | $3.56B | $3.38B | $3.14B | $2.61B |
| Current assets | $1.89B | $1.48B | $1.55B | $1.43B | $1.36B | $1.37B | $1.29B | $1.33B | $1.16B | $1.27B |
| Cash and equivalents | $402.42M | $223.84M | $223.64M | $141.73M | $122.92M | $300.14M | $241.97M | $261.82M | $712.64M | $466.29M |
| Total liabilities | $2.54B | $1.95B | $2.13B | $2.14B | $2.16B | $2.14B | $1.99B | $1.95B | $488.18M | $1.43B |
| Short-term debt | $343.53M | $338.29M | $458.22M | $122.79M | $289.63M | $117.87M | $110.25M | $163.97M | $66.78M | $173.82M |
| Long-term debt | $1.14B | $688.07M | $681.19M | $1.05B | $907.02M | $1.05B | $1.09B | $1.13B | $1.19B | $772.74M |
| Shareholder equity | $2.67B | $2.47B | $2.31B | $2.05B | $1.97B | $1.85B | $1.57B | $1.42B | $1.30B | $1.17B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.11B | $5.13B | $5.10B | $5.25B | $5.10B | $4.87B | $4.53B | $4.43B | $4.63B | $4.45B | $4.44B | $4.45B |
| Total liabilities | $2.45B | $2.46B | $2.42B | $2.54B | $2.29B | $2.15B | $1.98B | $1.95B | $2.07B | $2.04B | $2.07B | $2.13B |
| Cash and equivalents | $204.18M | $190.40M | $222.53M | $402.42M | $257.06M | $161.73M | $125.84M | $223.84M | $325.52M | $221.49M | $199.83M | $223.64M |
| Shareholder equity | $2.61B | $2.63B | $2.63B | $2.67B | $2.77B | $2.70B | $2.54B | $2.47B | $2.54B | $2.40B | $2.35B | $2.31B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 52.6% of operating cash flow. Dividends and share repurchases together came to 162.2% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $570.00M | $643.41M | $575.24M | $478.62M | $363.44M | $570.15M | $514.46M | $313.63M | $324.73M | $325.30M |
| Capital expenditures | $270.42M | $276.48M | $312.34M | $310.43M | $307.94M | $245.95M | $242.28M | $211.25M | $156.62M | $128.99M |
| Free cash flow | $299.58M | $366.93M | $262.90M | $168.19M | $55.51M | $324.20M | $272.18M | $102.38M | $168.10M | $196.31M |
| Dividends paid | $120.78M | $114.06M | $103.68M | $99.46M | $98.51M | $92.66M | $90.21M | $82.35M | $79.94M | $76.66M |
| Share repurchases | $365.00M | $68.64M | $47.55M | $92.13M | $78.15M | $0 | $86.50M | $3.90M | $120.54M | N/A |
| Investing cash flow | -$331.43M | -$396.72M | -$324.46M | -$295.64M | -$457.24M | -$451.98M | -$336.27M | -$735.46M | -$224.80M | -$300.50M |
| Financing cash flow | -$77.47M | -$225.34M | -$171.55M | -$162.10M | -$81.52M | -$73.72M | -$197.13M | -$14.87M | $114.79M | -$29.71M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $167.60M | $103.49M | $118.69M | $183.69M | $177.61M | $125.96M | $82.74M | $178.24M | $229.26M | $143.58M | $92.33M | $219.64M |
| Capital expenditures | $69.01M | $57.56M | $65.40M | $86.82M | $63.31M | $63.42M | $56.86M | $66.06M | $66.55M | $68.20M | $75.66M | $81.14M |
| Free cash flow | $98.59M | $45.92M | $53.30M | $96.87M | $114.29M | $62.53M | $25.88M | $112.17M | $162.71M | $75.37M | $16.67M | $138.49M |
Frequently Asked Questions About ATR
What is AptarGroup's annual revenue?
AptarGroup reported revenue of $3.78B for the fiscal year ended Dec 31, 2025.
How fast is AptarGroup's revenue growing?
Revenue was up 5.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 4.4%.
Is AptarGroup profitable?
Yes. AptarGroup reported net income of $392.50M for the fiscal year ended Dec 31, 2025, with a net margin of 10.4%.
How much free cash flow does ATR generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $570.00M minus capital expenditures of $270.42M produced free cash flow of $299.58M.
How much debt does AptarGroup have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.14B, short-term debt of $343.53M and cash and equivalents of $402.42M.
ATR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts